A: Change in HbA1c over time (mean ± SE) (mITT population). *mITT/MMRM. B: Percentage of responders reaching HbA1c at week 30 in the mITT population. *Weighted average of proportion difference between treatment groups. C: Mean ± SE and least squares (LS) mean change in body weight (mITT population). *mITT/MMRM; †LS mean difference vs. iGlar. D: Mean ± SE 7-point SMPG (mITT population). E: Patients achieving composite end points (mITT population). *Weighted average of proportion difference between treatment groups. BL, baseline; LOCF, last observation carried forward; S, screening.